Delivered by the Queensland University of Technology (QUT) in collaboration with a consortium of partners, including Biodesign Australia, along with leading pharmaceutical companies, universities, and industry affiliates. The Bridge Program leverages partner expertise and global connections to equip you with the skills and networks you need to take new medicines to market.  Launched in 2017, the program selects 100 participants annually from across Australia to take part in face-to-face and online training in the various disciplines that contribute to the commercialisation of new medicines. The tacit industry knowledge that the Bridge Program consortium provides makes the program unique in its integration into venture capital and global pharmaceutical networks and its ability to share specific, detailed and practical know-how.